OBJECTIVE	Vascular endothelial growth factor A ( VEGF-A ) and vascular endothelial growth factor receptor 2 ( VEGFR2 ) are often coexpressed in breast cancer , and potentially affect cellular pathways and key proteins such as the estrogen receptor ( ER ) targeted by endocrine treatment .\